BIOA

BioAge Labs, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website -
Employees(FY) -
ISIN US09077V1008

Performance

-74.38%

-79.86%

-75.59%

YTD

-75.59%

Profile

Advanced Technical Analysis

Stock Analysis of BIOA

Stock Rank

Recent News & Updates

2024-12-09 09:28
BioAge halts ongoing Phase II trial of obesity drug due to liver concerns(Clinical Trials Arena)
2024-12-09 07:41
Top Premarket Decliners(MT Newswires)
2024-12-09 07:41
Just Two Months After IPO, BioAge Labs Stops Eli Lilly-Collaborated Obesity Trial On Safety Concerns(Benzinga)
2024-12-09 06:51
BioAge Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosures Hagens Berman(Globenewswire)
2024-12-07 06:34
BioAge shares tumble after decision to halt obesity drug study(BioPharma Dive)
2024-12-06 17:08
BioAge Labs Terminates Phase 2 Trial of Obesity Drug Candidate(MT Newswires)
2024-12-06 16:35
BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of Obesity(GlobeNewswire)
2024-12-06 03:35
BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of Obesity(Globenewswire)
2024-12-05 16:30
BioAge Labs to Present at Goldman Sachs “Year-Ahead” Catalyst Clinic(GlobeNewswire)
2024-12-05 03:30
BioAge Labs to Present at Goldman Sachs Year-Ahead Catalyst Clinic(Globenewswire)
2024-12-04 16:47
Why BioAge Labs (BIOA) is the Best All-Time Low Stock to Buy Right Now?(Insider Monkey)
2024-11-21 16:30
BioAge Labs to Present at Upcoming Investor Conferences(GlobeNewswire)
2024-11-21 03:30
BioAge Labs to Present at Upcoming Investor Conferences(Globenewswire)
2024-11-12 23:01
BioAge Labs Reports Strong Q3 2024 Achievements(TipRanks)
2024-11-07 16:30
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates(GlobeNewswire)
2024-11-07 03:30
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates(Globenewswire)
2024-11-04 09:00
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024(GlobeNewswire)
2024-11-03 20:00
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024(Globenewswire)
2024-10-24 09:00
BioAge Labs to Present at Jefferies London Healthcare Conference(GlobeNewswire)
2024-10-23 21:00
BioAge Labs to Present at Jefferies London Healthcare Conference(Globenewswire)
2024-10-21 10:53
Wall Street analysts initiate coverage of BioAge Labs(Investing.com)
2024-10-16 21:45
Prediction: These 2 Stocks Could Soar in 2025(Yahoo Finance)
2024-10-12 14:31
Interested in Weight Loss Stocks Besides Novo Nordisk and Eli Lilly? You Might Want To Check Out This New IPO Stock(Motley Fool)
2024-10-07 21:10
RA Capital Management, L.P. Acquires New Stake in Bioage Labs Inc(GuruFocus.com)
2024-10-05 07:15
3 Reasons to Buy BioAge Labs Stock Hand Over Fist in October(Motley Fool)
2024-10-03 09:05
This IPO Biotech Stock Could Be the Next Eli Lilly(Motley Fool)
2024-10-01 17:22
BioAge Labs Raises $238.3 Million From IPO, Private Placement(MT Newswires)
2024-10-01 16:30
BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of the Concurrent Private Placement(GlobeNewswire)
2024-10-01 04:30
BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of the Concurrent Private Placement(Globenewswire)
2024-09-26 16:08
BioAge Labs, An Obesity Newcomer And Eli Lilly Partner, Rises On Upsized IPO(Investor's Business Daily)

Page 1 of 2

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.